Transforming growth factor-beta in the regulation of the immune response.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Clinical Immunology and Immunopathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1395120
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-Type Plasminogen Activator

  2012cited by this paper
• Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells

  2004cited by this paper
• Transforming growth factor-beta induces human T lymphocyte migration in vitro.

  1991cited by this paper
• Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins.

  1991cited by this paper
• Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF‐β

  1991cited by this paper
• Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.

  1991cited by this paper
• TGF-beta: a possible autocrine immune regulator.

  1991cited by this paper
• Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.

  1991cited by this paper
• Cognate interactions between helper T cells and B cells. VI. TGF-beta inhibits B cell activation and antigen-specific, physical interactions between Th and B cells.

  1991cited by this paper
• Transforming growth factor-beta and suppression of humoral immune responses in HIV infection.

  1991cited by this paper
• Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β

  1991cited by this paper
• Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression.

  1991cited by this paper
• Transforming growth factor type beta 1 (TGF‐β1) down‐regulates interleukin‐2 production and up‐regulates interleukin‐2 receptor expression in a thymoma cell line

  1991cited by this paper
• Cancer invasion and metastases.

  1990cited by this paper
• The Transforming Growth Factor‐Betas: A New Family of Immunoregulatory Molecules

  1990cited by this paper
• Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.

  1990cited by this paper
• Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection.

  1990cited by this paper
• Transforming growth factor-beta. Effect on soft tissue repair.

  1990cited by this paper
• Transforming growth factor-beta and cellular immune responses in synovial fluids.

  1990cited by this paper
• Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta

  1990cited by this paper
• Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation.

  1990cited by this paper
• Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer.

  1990cited by this paper
• Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

  1990cited by this paper
• The cell biology of transforming growth factor beta.

  1990cited by this paper
• Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

  1990cited by this paper
• Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium.

  1990cited by this paper
• Two Forms of Transforming Growth Factor‐β Are Equally Potent Selective Growth Inhibitors of Early Murine Hematopoiesis a b

  1990cited by this paper
• Immunosuppressive effects of transforming growth factor beta: inhibition of the induction of Ia antigen on Langerhans cells by cytokines and of the contact hypersensitivity response.

  1990cited by this paper
• Suppression of lymphokine‐activated killer (LAK) cell induction mediated by interleukin‐4 and transforming growth factor‐β1: effect of addition of exogenous tumour necrosis factor‐alpha and interferon‐gamma, and measurement of their endogenous production

  1990cited by this paper
• Modulation of cytokine production by transforming growth factor-beta.

  1989cited by this paper
• Transforming growth factor-beta and suppression of carcinogenesis.

  1989cited by this paper
• Cytokine regulation of interleukin 6 production by human endothelial cells.

  1989cited by this paper
• IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

  1989cited by this paper
• Active and latent forms of transforming growth factor beta activity in synovial effusions

  1989cited by this paper
• The interleukins 1

  1989cited by this paper
• Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.

  1989cited by this paper
• Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils

  1989cited by this paper
• Transforming growth factor beta.

  1988cited by this paper
• Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

  1988cited by this paper
• Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

  1988cited by this paper
• Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

  1988cited by this paper
• Deactivation of macrophages by transforming growth factor-beta.

  1988cited by this paper
• Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors.

  1988cited by this paper
• Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.

  1988cited by this paper
• Transforming growth factor-beta s are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation.

  1988cited by this paper
• Regulation of colony-stimulating factor 1-dependent macrophage precursor proliferation by type beta transforming growth factor.

  1988cited by this paper
• Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

  1988cited by this paper
• Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

  1988cited by this paper
• Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta

  1988cited by this paper
• Effect of tumor necrosis factor alpha on mitogen-activated human B cells

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

  1987cited by this paper
• Membrane binding characteristics of two forms of transforming growth factor-beta.

  1987cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Distribution and modulation of the cellular receptor for transforming growth factor-beta

  1987cited by this paper
• Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

  1987cited by this paper
• Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

  1987cited by this paper
• Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

  1987cited by this paper
• B-cell stimulatory factors (BSFs): Molecular structure, biological function, and regulation of expression

  1987cited by this paper
• Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

  1987cited by this paper
• Tumors secreting human TNF/cachectin induce cachexia in mice.

  1987cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

  1987cited by this paper
• Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

  1986cited by this paper
• Peptide growth factors and inflammation, tissue repair, and cancer.

  1986cited by this paper
• Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

  1986cited by this paper
• Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.

  1986cited by this paper
• The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

  1986cited by this paper
• Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells.

  1986cited by this paper
• Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.

  1986cited by this paper
• Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.

  1986cited by this paper
• Enhanced production and extracellular deposition of the endothelial- type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta

  1986cited by this paper
• Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors.

  1986cited by this paper
• Shock and tissue injury induced by recombinant human cachectin.

  1986cited by this paper
• Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

  1986cited by this paper
• Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells

  1986cited by this paper
• The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants

  1985cited by this paper
• A burn induced Ly-2 suppressor T cell lowers resistance to bacterial infection.

  1985cited by this paper
• Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

  1985cited by this paper
• Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions.

  1985cited by this paper
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells

  1985cited by this paper
• Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

  1985cited by this paper
• Human interleukin 1 mediates cartilage matrix degradation.

  1985cited by this paper
• Interleukin 1 increases collagen type IV production by murine mammary epithelial cells.

  1985cited by this paper
• Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat

  1985cited by this paper
• Type beta transforming growth factor: a bifunctional regulator of cellular growth.

  1985cited by this paper
• Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.

  1984cited by this paper
• NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment.

  1984cited by this paper
• Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon.

  1984cited by this paper
• Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

  1984cited by this paper
• Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.

  1984cited by this paper
• Septic shock. Hemodynamics and pathogenesis.

  1983cited by this paper
• Interleukin 1 stimulation of collagenase production by cultured fibroblasts

  1983cited by this paper
• The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains.

  1983cited by this paper
• Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity.

  1983cited by this paper
• Tumor induced immunosuppression.

  1983cited by this paper
• Characterization of blood mononuclear cells of rheumatoid arthritis patients. I. Depressed lymphocyte proliferation and enhanced prostanoid release from monocytes.

  1982cited by this paper
• Interleukin 1, a potential regulator of fibroblast proliferation.

  1982cited by this paper
• Serum contains a platelet-derived transforming growth factor.

  1982cited by this paper
• Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

  1981cited by this paper

• The anti-inflammatory and immunomodulatory effects of olfactory ensheathing cells transplantation in spinal cord injury and concomitant pathological pain.

  2024cites this paper
• The Dual Role of Myeloperoxidase in Immune Response

  2020cites this paper
• Human PZP and common marmoset A2ML1 as pregnancy related proteins

  2020cites this paper
• Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone

  2017cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• Infusion of Bone Marrow Mononuclear Cells Reduces Lung Fibrosis but Not Inflammation in the Late Stages of Murine Silicosis

  2014cites this paper
• Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children.

  2013cites this paper
• Einfluss der Druckbelastung des rechten Ventrikels auf die Expression von Wachstums- und Apoptosefaktoren

  2009cites this paper
• TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus.

  2007cites this paper
• Immunomodulation and vaccination for atherosclerosis

  2004cites this paper
• Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis.

  2003cites this paper
• Modulation of Immune System Function by Measles Virus Infection. II. Infection of B Cells Leads to the Production of a Soluble Factor That Arrests Uninfected B Cells in G0/G1

  2003cites this paper
• Nonthermal effects of therapeutic ultrasound: the frequency resonance hypothesis.

  2002cites this paper
• Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

  2001cites this paper
• Serum TGF-beta in thermally injured rats.

  2001cites this paper
• Transforming growth factor-beta(1), -beta(2), -beta(3) and their type I and II receptors in human term placenta.

  2000cites this paper
• Impact of burn injury on hepatic TGF-beta1 expression and plasma TGF-beta1 levels.

  2000cites this paper
• Quantitative polymerase chain reaction for transforming growth factor-beta applied to a field study of fish health in Chesapeake Bay tributaries.

  2000cites this paper
• Perichondrial chondrogenesis and periosteal osteogenesis by localized graft-vs-host reaction in mice.

  2000cites this paper
• Correlation of Transforming Growth Factor-β Messenger RNA (TGF-β mRNA) Expression with Cellular Immunoassays in Triamcinolone-Treated Captive Hybrid Striped Bass.

  2000cites this paper
• Transforming growth factor-beta1 and splenocyte apoptotic cell death after burn injuries.

  2000cites this paper
• Transforming growth factor-beta impairs postburn immunoglobulin production by limiting B-cell proliferation, but not cellular synthesis.

  1999cites this paper
• Local hypertrophic/hyperplastic changes of keratinizing squamous epithelium of pinna induced by concanavalin A and other immunomodulators in mice.

  1999cites this paper
• Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors.

  1999cites this paper
• Do alcohol and cocaine abuse alter the course of HIV‐associated dementia complex?

  1999cites this paper
• Concentration- and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1alpha in rat alveolar macrophages by fungal spores implicated in airway inflammation.

  1998cites this paper
• Augmented levels of macrophage and Th1 cell‐related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis

  1998cites this paper
• Caspase inhibitor BD-fmk distinguishes transforming growth factor beta-induced apoptosis from growth inhibition.

  1998cites this paper
• The lens influences aqueous humor levels of transforming growth factor-beta 2.

  1998cites this paper
• Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis.

  1998cites this paper
• [Cytokines in the immunopathogenesis of multiple sclerosis].

  1997cites this paper
• Role of transforming growth factor-beta 1 and -beta 2 in ddY mouse nephropathy.

  1997cites this paper
• Cellular changes and cytokine expression in the ilea of gnotobiotic piglets resulting from peroral Salmonella typhimurium challenge

  1997cites this paper
• Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression.

  1996cites this paper
• Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1.

  1996cites this paper
• Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis.

  1996cites this paper
• Characterization of the Growth Factor Activity of Amniotic Fluid on Cells from Hematopoietic and Lymphoid Organs of Different Life Stages

  1996cites this paper
• Intravenous immune globulin affects cytokine production in T lymphocytes and monocytesjmacrophages

  1996cites this paper
• Mucosal Tolerance to Experimental Autoimmune Myasthenia Gravis Is Associated with Down‐regulation of AChR‐specific IFN‐γ‐expressing Th1‐like Cells and Up‐regulation of TGF‐β mRNA in Mononuclear Cells

  1996cites this paper
• Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers?

  1996cites this paper
• Intravitreal transforming growth factor-beta 2 decreases cellular infiltration in endotoxin-induced ocular inflammation in rabbits.

  1996cites this paper
• Cellular mRNA expression of interferon‐gamma (IFN‐γ), IL‐4 and transforming growth factor‐beta (TGF‐β) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG)

  1996cites this paper
• Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity.

  1995cites this paper
• Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.

  1995cites this paper
• Neutralizing inflammatory cytokines in nephritis.

  1995cites this paper
• Cytokines in Sjögren's syndrome.

  1995cites this paper
• SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice.

  1995cites this paper
• Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome.

  1995cites this paper
• Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis

  1995cites this paper
• Cytokines as mediators of autoimmune diabetes and diabetic complications.

  1995cites this paper
• Increased translocation of Escherichia coli and development of arthritis in vitamin A-deficient rats

  1995cites this paper
• Cloning of a canine cDNA homologous to the human transforming growth factor-beta 1-encoding gene.

  1995cites this paper
• The immunoregulatory roles of transforming growth factor beta.

  1995cites this paper
• Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation.

  1994cites this paper
• Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.

  1994cites this paper
• Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment.

  1994cites this paper
• Induction of resistance to mineralocorticoid hormone in cultured inner medullary collecting duct cells by TGF-beta 1.

  1994cites this paper
• Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology.

  1994cites this paper
• Differential effect of transforming growth factor-beta 1 on the activation of human naive and memory CD4+ T lymphocytes.

  1994cites this paper
• Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta.

  1994cites this paper
• The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-beta 1) and beta 2 activity.

  1994cites this paper
• Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve

  1994cites this paper
• Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint.

  1994cites this paper
• Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand.

  1994cites this paper
• Augmented interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in blood mononuclear cells in myasthenia gravis.

  1994cites this paper
• Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis

  1994cites this paper
• Organ‐specific autoantigens induce transforming growth factor‐β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

  1994cites this paper
• Defective production of IFN-gamma in neonatally tolerant mice: involvement of IL-10.

  1994cites this paper
• Inhibition of lymphocyte adherence to rat lacrimal acinar epithelium by interleukin-4 and transforming growth factor-beta 1.

  1994cites this paper
• Pooled Human IgG Modulates Cytokine Production in Lymphocytes and Monocytes

  1994cites this paper
• Transforming growth factor-beta up-regulates the gene expression of the human platelet-activating factor receptor in monocytic and B cell lines.

  1993cites this paper
• Transgenic mice in the study of cytokine function.

  1993cites this paper